These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

51 related articles for article (PubMed ID: 4340402)

  • 1. [Pharmacokinetics of a hepatotropic and a renotropic x-ray contrast medium during hemodialysis].
    Siemensen HC; Augustin HJ
    Fortschr Geb Rontgenstr Nuklearmed; 1972 Jun; 116(6):799-807. PubMed ID: 4340402
    [No Abstract]   [Full Text] [Related]  

  • 2. Pharmacokinetics of a hepatotropic and a renotropic x-ray contrast agent under haemodialysis.
    Siemensen HC; Augustin HJ
    Int Urol Nephrol; 1973 Apr; 5(2):195-204. PubMed ID: 4774523
    [No Abstract]   [Full Text] [Related]  

  • 3. [Elimination of iodine-containing hepatotropic and renotropic roentgen contrast media in peritoneal dialysis].
    Augustin HJ; Siemensen HC
    Z Urol Nephrol; 1974 Apr; 67(4):247-54. PubMed ID: 4848641
    [No Abstract]   [Full Text] [Related]  

  • 4. [Pharmacokinetics of diatrizoate during hemodialysis].
    Siemensen HC; Augustin HJ
    Int J Clin Pharmacol; 1973 Aug; 8(1):22-9. PubMed ID: 4727445
    [No Abstract]   [Full Text] [Related]  

  • 5. Iosulamide: a new intravenous cholangiocholecystographic medium.
    Rosenberg FJ; Ackerman JH; Nickel AR
    Invest Radiol; 1980; 15(6 Suppl):S142-7. PubMed ID: 6782035
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Contrast medium elimination by hemodialysis].
    Baars HG; Schabel J; Weiss M
    Z Urol Nephrol; 1984 Aug; 77(8):473-81. PubMed ID: 6495896
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Renal transport of diatrizoate in the rabbit, dog, and rat.
    Mudge GH; Berndt WO; Saunders A; Beattie B
    Nephron; 1971; 8(2):156-72. PubMed ID: 5119527
    [No Abstract]   [Full Text] [Related]  

  • 8. Differential effect of chronic renal failure on the pharmacokinetics of lidocaine in patients receiving and not receiving hemodialysis.
    De Martin S; Orlando R; Bertoli M; Pegoraro P; Palatini P
    Clin Pharmacol Ther; 2006 Dec; 80(6):597-606. PubMed ID: 17178261
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Significance of the liver cell in elimination of cholegraphic agents (author's transl)].
    Otto H
    Radiologe; 1980 Jan; 20(1):16-23. PubMed ID: 7360933
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Renal excretion of iodipamide. Comparative study in the dog and rabbit.
    Berndt WO; Mudge GH
    Invest Radiol; 1968; 3(6):414-26. PubMed ID: 5712518
    [No Abstract]   [Full Text] [Related]  

  • 11. Elimination of diatrizoate by peritoneal dialysis in renal failure.
    Milman N; Christensen E
    Acta Radiol Diagn (Stockh); 1974 May; 15(3):265-72. PubMed ID: 4843638
    [No Abstract]   [Full Text] [Related]  

  • 12. Pharmacokinetics of moxalactam in anuric children and during hemodialysis.
    Kaplan SL; Berry PL; Mason EO; Kramer WG
    Pediatr Pharmacol (New York); 1983; 3(1):29-36. PubMed ID: 6646877
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Particulate contrast media for computed tomographic scanning of the liver.
    Violante MR; Dean PB; Fischer HW; Mahoney JA
    Invest Radiol; 1980; 15(6 Suppl):S171-5. PubMed ID: 7203919
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics of lenalidomide in subjects with various degrees of renal impairment and in subjects on hemodialysis.
    Chen N; Lau H; Kong L; Kumar G; Zeldis JB; Knight R; Laskin OL
    J Clin Pharmacol; 2007 Dec; 47(12):1466-75. PubMed ID: 17954615
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A new animal model for testing renal tolerance of contrast agents.
    Krause W; Gilles T
    Invest Radiol; 2003 Nov; 38(11):704-11. PubMed ID: 14566180
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics of dyphylline elimination by uremic patients.
    Lee CC; Wang LH; Majeske BL; Marbury TC
    J Pharmacol Exp Ther; 1981 May; 217(2):340-4. PubMed ID: 7229976
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cefsulodin pharmacokinetics during hemodialysis.
    Matzke GR; Keane WF
    Trans Am Soc Artif Intern Organs; 1982; 28():324-8. PubMed ID: 7164256
    [No Abstract]   [Full Text] [Related]  

  • 18. Estimation of residual glomerular filtration rate and renal Kt/Vurea from creatinine clearance in end-stage renal disease patients. The Netherlands Cooperative Study on the Adequacy of Dialysis.
    Korevaar JC; Jansen MA; Dekker FW; Boeschoten EW; Krediet RT
    Adv Perit Dial; 1999; 15():132-7. PubMed ID: 10682088
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Elimination of hepatotrophic biliary contrast media].
    Otto H
    Fortschr Med; 1981 Jan; 99(3):66-9. PubMed ID: 7203346
    [No Abstract]   [Full Text] [Related]  

  • 20. A primer on pharmacokinetics.
    Quan DJ
    Nephrol Nurs J; 2008; 35(2):213-5. PubMed ID: 18472692
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.